Market Research Blog – Page 551 – New Product Development

Food and Grocery Retail Market Adapting to Consumer Preferences in a Dynamic Retail Landscape

The current valuation of the food and grocery retail market is US$ 12.4 trillion by 2024. The market valuation is estimated to be US$ 17.1 trillion by 2034, projected at a CAGR of 3.3%.

Growing awareness about health and wellness has spurred demand for organic, natural, and health-conscious food products. Retailers catering to these preferences are experiencing accelerated growth as they offer diverse nutritious options aligning with evolving dietary trends.

In the last five years, the food and grocery retail sector has shown steady growth, achieving a CAGR of 5.3% from 2019 to 2023. This period marked a surge in consumer demand driven by changing preferences, population growth, and the adoption of new shopping behaviors.

Innovation in technology, such as artificial intelligence (AI), data analytics, and the Internet of Things (IoT), propels efficiency and innovation across the food and grocery retail supply chain.

Despite technological advancements, the food and grocery retail market remains susceptible to supply chain disruptions caused by natural disasters, geopolitical tensions, and global health crises.

Intense competition, price wars, and aggressive marketing strategies can exert downward pressure on profit margins and limit growth opportunities for retailers.

Key Takeaways from the Market Study

Based on product type, the fresh food is registered at a CAGR of 3.1% by 2034.
The United States is expected to register at a CAGR of 1.4% by 2034.
The United Kingdom registers significant growth, projected at a CAGR of 1.3% by 2034.
Based on distribution channel, the supermarkets and hypermarkets segment is registered at a CAGR of 2.9% by 2034.

“The modern consumers, especially those with busy lifestyles, prioritize convenience in their shopping experience where the demand has led to the rise of various convenience-oriented solutions such as online grocery shopping, meal kits, and ready-to-eat options in-store, thus pushing the food and grocery retail market to grow,” says Nandini Roy Choudhury, Client Partner at Future Market Insights.

Competitive Landscape

Intense competition drives innovation, price competitiveness, and strategic acquisitions. Players leverage technology and customer-centric strategies to enhance offerings and capture consumers’ evolving preferences. Some of the key developments are:

In January 2020, Walmart introduced Alphabot, a cutting-edge technology to enhance its grocery business. Alphabot streamlined picking, packing, and delivering online grocery orders, enabling Walmart to reinforce its position as America’s leading grocer and provided faster and more efficient service to shoppers.
In September 2023, C&S Wholesale Grocers, LLC (C&S) acquired 413 stores, eight distribution centers, and two offices. These assets became available following the planned merger between Kroger Co. and Albertsons Companies Inc.

Key Companies Profiled

Walmart
Costco Wholesale Corp.
7-ELEVEN, Inc.
Amazon.com Inc.
The Kroger Co.
Target Brands, Inc.
ALDI
AEON Co Ltd
Carrefour CA
Schwarz Gruppe

More Valuable Insights Available

Future Market Insights offers an unbiased global food and grocery retail market analysis, providing historical data from 2019 to 2023 and forecast statistics from 2024 to 2034

To understand market opportunities, the food and grocery retail market is segmented based on Product (Fresh Food, Frozen Food, Food Cupboard, Beverages, Cleaning & Household, Others), Distribution Channel (Supermarkets & Hypermarkets, Convenience Stores, Departmental Stores, Online) and Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and the Middle East and Africa).

Key Segments

By Product:

Fresh Food
Frozen Food
Food Cupboard
Beverages
Cleaning & Household
Others

By Distribution Channel:

Supermarkets & Hypermarkets
Convenience Stores
Departmental Stores
Online

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Food Fortification Market Addressing Nutritional Deficiencies through Enriched Food Products

The food fortification market size is to be valued at US$ 106.7 billion by 2024. The market valuation is estimated to be US$ 286 billion by 2034, projected at a CAGR of 10.4%.

The food fortification market stands as a beacon of innovation and public health, leveraging fortified foods and beverages to address nutritional deficiencies and enhance overall well-being and imposes marketing strategies for promoting fortified food products to health-conscious consumers.

A surge in awareness of malnutrition and its impact on public health has spurred government initiatives and industry collaborations to fortify staple foods with essential nutrients. Consumer demand for functional foods and personalized nutrition solutions has fueled innovation in fortification techniques and product formulations, driving market expansion and diversification.

Food Fortification industry also faces challenges and opportunities for fortifying plant-based alternatives. Regulatory complexities and inconsistencies across different regions pose hurdles for market players, requiring compliance efforts and adaptability to navigate varying regulatory landscapes.

Consumer skepticism and misinformation regarding fortified foods may hinder adoption rates, highlighting the importance of education and transparency in fortification initiatives.

Opportunities lie in innovation, education, and expanding market reach to underserved populations, while threats include regulatory hurdles, competitive pressures, and misinformation about fortified foods.

Report Scope

Attributes	Details
Estimated Market Size in 2024	US$ 106.7 billion
Projected Market Valuation in 2034	US$ 286 billion
Value-based CAGR 2024 to 2034	10.4 %
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in US$ billion
Key Market Segments Covered	By Type: Proteins & Amino Acids Vitamins Lipids Prebiotics & Probiotics Carbohydrates Minerals Others By Process: Drum Dying Dusting By Application: Infant Formula Dairy & Dairy-Based Products Cereals & Cereal-Based Products Fats & oils Beverages Dietary Supplements Others By Region: North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East and Africa
Key Countries Profiled	The United States Canada Brazil Mexico Germany The United Kingdom France Spain	Italy Russia Poland Czech Republic Romania India Bangladesh Australia	New Zealand China Japan South Korea GCC countries South Africa Israel

Key Takeaways from the Market Study

Based on the type, the proteins and amino acids segment is registered at a CAGR of 10.2% by 2034.
The United States is expected to register at a CAGR of 10.7% by 2034.
The United Kingdom registers significant growth, projected at a CAGR of 11.7% by 2034.
Based on process, the drum dying segment is registered at a CAGR of 10% by 2034.

“The ascending prevalence of malnutrition and related health concerns globally. As the driver underscores the importance of fortification initiatives in combating malnutrition and promoting public health, propelling demand for fortified foods and beverages across various demographics and geographical regions of the industry,” says Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.).

Competitive Landscape

The food fortification ecosystem boasts a competitive landscape characterized by multinational corporations like Nestlé, Kellogg’s, and General Mills alongside regional players.

Intense competition drives innovation and collaboration, with a focus on expanding product portfolios and meeting diverse consumer preferences for fortified foods and beverages.

Some of the key developments are:

In 2021, Evolve BioSystems invested in Cargill and Manna Tree to advance its pioneering probiotic technology aimed at bolstering infant gut health. This partnership fueled research and development efforts in California, with a primary focus on optimizing the health and well-being of newborns through innovative probiotic solutions.
In 2022, FMC Corporation unveiled a groundbreaking technology aimed at revolutionizing the food fortification market. This development introduced a novel approach to fortifying staple foods with essential nutrients, enhancing their nutritional value, and addressing global malnutrition challenges.

More Valuable Insights Available

Future Market Insights offers an unbiased global food fortification market analysis, providing historical data from 2019 to 2023 and forecast statistics from 2024 to 2034.

To understand market opportunities, the food fortification market is segmented based on Type (Proteins & Amino Acids, Vitamins, Lipids, Prebiotics & Probiotics, Carbohydrates, Minerals, Others), Process (Drum Dying, Dusting), Application (Infant Formula, Dairy & Dairy-Based Products, Cereals & Cereal-Based Products, Fats & oils, Beverages, Dietary Supplements, Others), and Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and the Middle East and Africa).

About Future Market Insights (FMI)

Contact Us:

Skincare Supplement Market: Empowering Beauty from Within with Functional Ingredients

The global skincare supplement market size is projected to reach US$ 2,780 million in 2024. It is estimated to attain a valuation of around US$ 4,500 million by 2034. The industry is set to witness a CAGR of 8.8% in the forecast period 2024 to 2034.

Functionalities such as skin de-aging, wounds & marks healing, skin brightening, skin hydrating, and acne reduction have captured the demand for effective skincare products and are driving growth. The shift of consumers toward natural and organic alternatives of harmful skincare creams and gels, as well as rising awareness among consumers regarding preventive healthcare, are principal factors for a strong growth rate.

Research & development investments are also a key factor in the growth of the market, as advancements in experimenting and analyzing various formulae have led to the rise of effective supplements sourced from natural ingredients. Out-of-the-box marketing techniques such as regularizing skincare supplements among the masses and reaching out to aging populations around the world point to significant growth for the skincare supplement industry.

Key Takeaways from the Global Skincare Supplement Market Study:

By functionally, the skin de-aging category is projected to remain at the forefront by showcasing a CAGR of 10.9% through 2034.
By sales channel, health & wellness stores are set to exhibit a CAGR of 7.4% from 2024 to 2034.
The form segment is projected to be led by capsules with an 8.8% CAGR through 2034.
India is estimated to witness a CAGR of 6.4% from 2024 to 2034.
The United States is set to rise at a CAGR of 5.3% from 2024 to 2034.

“Increasing use of social media platforms like Snapchat and Instagram is compelling individuals to move toward natural supplements to bolster their skin’s appearance and prevent issues like acne. Hence, leading players are launching unique formulations to attract a large consumer base,” says a lead analyst at Future Market Insights (FMI).

Who is Winning?

Only a new product with exceptional functionality and competitive price can become successful, as the skincare supplement market is a consumer-driven one, with price and effectiveness playing significant roles in the adoption of a product. Companies able to create such products and distribute them effectively to a specific consumer base hold the potential for share expansion.

Some of these leaders of the global skincare supplement market include Amway, HUM Nutrition Inc, Nestle, Meiji Holdings Co Ltd, Shiseido Co Ltd, Unilever, Johnson & Johnson, Perricone MD, and Vitabiotics Ltd. For instance,

Nutrafol, a New York-based skincare brand, introduced Nutrafol Skin in February 2024. It is a new supplement for consumption on a daily basis to prevent acne. The supplement can improve post-acne dark spots and mild-to-moderate acne problems.

Key Segments of Market Report

By Functionality:

Few of the leading functionalities include skin de-aging, skin hydration, acne reduction, wound and mark healing, and skin brightening.

By Form:

In terms of form, the industry is segregated into tablets/pills, capsules, liquid, powder, gummies/chewables, and others.

By Sales Channel:

Hypermarkets/supermarkets, specialty stores, e-commerce, drug stores and pharmacies, health and wellness stores, convenience stores, and departmental stores.

By Region:

Information about key countries across South Asia, East Asia, Oceania, North America, Latin America, Europe, and the Middle East and Africa is provided.

About Future Market Insights (FMI)

Contact Us:

Global Orthopedic Navigation Systems Market Poised for Significant Growth, Set to Reach USD 13.2 Billion by 2033 with a CAGR of 16.9%

The global orthopedic navigation systems market is on track for substantial growth, with revenues estimated at USD 2.8 billion in 2023 and projected to soar to USD 13.2 billion by 2033, according to a recent report by Future Market Insights. The market is expected to expand at a robust compound annual growth rate (CAGR) of 16.9% over the forecast period.

One of the key drivers of this growth is increasing government investment in research and development for surgical navigation systems. Such initiatives are fueling advancements in technology, improving precision in orthopedic surgeries, and enhancing patient outcomes. However, challenges remain, particularly the high cost of these systems and occasional product recalls, which are likely to hinder market expansion to some extent.

In response, companies in the sector are focusing on raising awareness about the benefits of orthopedic navigation systems among healthcare professionals and patients. In developed markets, manufacturers are actively engaging with local communities and medical professionals through Continuing Medical Education (CME) programs. These initiatives are fostering greater adoption of the technology, as more physicians become familiar with the systems’ capabilities.

In addition to training efforts, orthopedic navigation systems currently available in the market are often sold with six to seven-year warranties, ensuring a steady sales cycle over this period. This, coupled with the growing demand for technology-assisted orthopedic treatments, is expected to support continued market growth throughout the forecast period.

With the ongoing advancements and increasing adoption, the orthopedic navigation systems market is set to redefine how orthopedic surgeries are performed, delivering greater accuracy and improved patient outcomes globally.

Key Takeaways: Global Orthopedic Navigation Systems Market

The global orthopedic navigation systems market is projected to experience significant growth, with revenues expected to increase from USD 2.8 billion in 2023 to USD 13.2 billion by 2033, representing a CAGR of 16.9%.
Key drivers of this growth include increasing demand for minimally invasive surgeries, advancements in technology, and rising healthcare spending.

The United States dominates the market, accounting for a significant share and expected to reach a valuation of USD 5.2 billion by 2033.
The United Kingdom and Japan are also anticipated to experience substantial growth, with projected market values of USD 1.1 billion and USD 539 million, respectively.
South Korea is expected to have a smaller market size but is still projected to grow at a steady pace.

Orthopedic imaging-guided surgical systems are commonly used in various procedures, including complete knee arthroplasty, total hip arthroplasty, anterior cruciate ligament restoration, trauma, and corrective surgeries.

Orthopedic Navigation Systems Market Insights: Access Our Full Report for a Deep Dive into Emerging Trends!

Competitive Landscape:

The key players operating in Orthopedic Navigation Systems Market include Stryker, Medtronic, Johnson & Johnson Services, B. Braun Melsungen AG, Smith + Nephew, OrthAlign, Globus Medical, and Zimmer Biomet.

In February 2021, Brainlab, received FDA clearance for both Cirq and Loop-X Mobile Imaging Robot. Following the CE mark approval, the FDA’s clearance paved the way for Brainlab to enter the U.S. market with the Cirq robotic alignment module for spine procedures, and Loop-X, a fully robotic intraoperative imaging device on the market.
In January 2021, DePuy Synthes received 510(k) FDA clearance for VELYS robotic-assisted solution. It is designed for use with the ATTUNE total knee system.
In November 2020, Stryker, completed the acquisition of Wright Medical, in an attempt to enhance its market position globally in trauma and extremities. It will provide the company with significant opportunities to improve outcomes, advance innovation, and increase patient reach.
In July 2020, Smith + Nephew, publicized the introduction of the RI.HIP Navigation for Total Hip Arthroplasty (THA). This device received 510(k) clearance from the U.S. FDA and CE Mark certification for THA.

Market Segments Covered in Orthopedic Navigation Systems Market Analysis

By Application:

Knee
Hip
Spine

By Technology:

Electromagnetic
Optical
Other Technologies

By End Use:

Hospitals
Ambulatory Surgery Centers

By Region:

North America
Latin America
Europe
APAC
Middle East and Africa(MEA)

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈’𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

Chemotherapy-Induced Oral Mucositis Industry

Fungal Staining Reagent Industry

Europe Platelet Rich Plasma (PRP) Industry

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Ulcerated Necrobiosis Lipoidica Management Market to Reach USD 7.9 Billion by 2033, Fueled by Advancements in Treatment and Diagnostics: FMI Study

The global market for ulcerated necrobiosis lipoidica management is set to witness substantial growth in the coming years, with an estimated market valuation of USD 4.4 billion in 2023. It is projected to reach USD 7.9 billion by 2033, expanding at a compound annual growth rate (CAGR) of 6.03% during the forecast period. The growth is primarily driven by innovations in diagnostic techniques, including magnetic resonance imaging (MRI), along with the increasing number of drug approvals and new treatment options emerging in the market.

Necrobiosis lipoidica, a rare skin condition associated with ulceration, has been a major focus for medical research and treatment development. As advanced diagnostic methods become more accessible, the ability to diagnose this condition early and accurately has significantly improved. This, in turn, is expected to accelerate the demand for effective treatments and interventions in the market.

One of the most prominent treatment approaches currently being adopted is photochemotherapy (PUVA therapy) and photodynamic therapy, which are expected to dominate the treatment landscape for ulcerated necrobiosis lipoidica. These therapies are gaining traction due to their efficacy in managing the condition, driving market growth further.

In addition, the global market is experiencing a surge in drug development and an increasing number of drugs undergoing clinical trials. This shift toward biological and technological advances in the treatment of ulcerated necrobiosis lipoidica will continue to play a crucial role in market expansion. The introduction of new drugs will not only improve treatment outcomes but also address the significant unmet needs in the market, including the lack of clinically proven treatments.

However, the market faces challenges, particularly the rising economic burden associated with ulcerated necrobiosis lipoidica treatment. The direct and indirect costs of long-term treatment and the absence of universally effective therapies highlight the need for innovative solutions. This gap presents significant opportunities for market players to develop new drugs aimed at addressing resistant bacteria and reducing treatment costs, thus paving the way for further growth.

Regulatory approvals will also play a key role in boosting market dynamics. A notable example is the approval of Baxdela (delafloxacin) by the United States Food and Drug Administration (FDA) in June 2017. Baxdela, a fluoroquinolone antibiotic, is used for severe bacterial skin infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA), and is expected to provide a valuable therapeutic option for ulcerated necrobiosis lipoidica patients.

As the market continues to expand, ongoing developments in treatment and diagnostics, coupled with the growing demand for effective solutions, will drive the growth of the global ulcerated necrobiosis lipoidica management market, positioning it for significant advancements over the next decade.

Key Takeaways:

North America is expected to dominate the industry while reaching market share of around 41% by end of the forecast period.
The market in Asia Pacific is projected to account for 32.8% market share by end of the projected period.
By treatment type, ‘UVA1 Phototherapy’ is projected to account for 31% market share by end of the forecast period.
Hospitals are expected to dominate the market by distribution channel, with a market share of 71% by 2033.

“Development of new clinically proven and effective drugs coupled with increasing healthcare expenditure is going to drive the treat market of Ulcerated necrobiosis lipoidica in the forecast period”- Comments an FMI Analyst

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Competitive Landscape:

The Ulcerated Necrobiosis Lipoidica Management Market is intensely competitive and consists of numerous key market players. These key players are developing novel delivery systems for treating ulcerated necrobiosis lipoidica. This is estimated to fuel Ulcerated Necrobiosis Lipoidica Management Market. The key players in this market are: Astellas Pharma, Vibcare Pharma, Pfizer, Manus Aktteva Biopharma LLP, Mylan Pharmaceuticals Inc., Upsher-Smith Laboratories, Novartis, Sanofi, Merck, GlaxoSmithKline.

Key industry players are inclined on adoption of inorganic growth strategies like acquisition, mergers, partnerships, and collaboration in order to strengthen their product portfolio. This is anticipated to fuel the global Ulcerated Necrobiosis Lipoidica Management Market.

In June 2022, Basilea Pharmaceutica Ltd declared positive topline results for the Phase III ERADICATE study, evaluating ceftobiprole in treating adult patients with bacterial bloodstream infections caused by Staphylococcus aureus.
In January 2022, Paladin Labs Inc., which is a subsidiary of Endo International PLC announced the launch of ‘Xydalba’ (dalbavancin for injection), a 30-minute intravenous therapy for chronic bacterial skin structure infections that can be administered as a single- or two-dose.
On July 7, 2021, Melinta Therapeutics, a pharmaceutical company, announced about launch of its product ‘KIMYRSA’. This drug is a lipoglycopeptide antibiotic that offers a complete course of treatment for chronic bacterial skin and skin structure infections including ulcerated necrobiosis lipoidica. This drug is effective in a single dose of 1200mg injection.

Key Segments Profiled in the Ulcerated Necrobiosis Lipoidica Management Industry Survey:

By Treatment:

Skin Grafting
Photodynamic Therapy
UVA1 Phototherapy
Topical Psoralen-UVA Therapy
Drugs
- Antimalarial Agents
- Antitubercular Agents
- Immunosuppressive Agents
- Hemorrheologic Agents
- Fumaric Acid Esters
- Calcineurin Inhibitors
- Corticosteroids

By End User:

Hospitals
Specialty Clinics
Others

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Specialty Control Plasma Industry

Self-urinary Infection Testing Industry

Antibacterial Haemostatic Gels Industry

About Future Market Insights (FMI)

Contact Us:

Global Retinal Vein Occlusion Treatment Market Set to Double in Value USD 4.7 Billion by 2033 at a 5.9% CAGR

The global retinal vein occlusion treatment market is on the brink of remarkable growth, with its valuation projected to rise from USD 2.3 billion in 2023 to USD 4.7 billion by 2033. This growth reflects a robust compound annual growth rate (CAGR) of 5.9%, highlighting the increasing demand for effective treatments for this common retinal vascular disease among older adults.

RVO, a significant cause of vision loss, predominantly affects individuals over the age of 65. As the global population continues to age, the incidence of RVO is expected to surge, driving the demand for advanced therapeutic options. Key players in the market are capitalizing on this trend by scaling up the production of corticosteroid drugs, which are essential in managing the inflammatory aspects of the condition and reducing associated edema.

Anti-vascular endothelial growth factor (anti-VEGF) medications such as Lucentis, Avastin, and Eylea are frequently used in treating BRVO cases with neovascularization or macular edema. These treatments are critical in managing the condition and improving patient outcomes.

The market is also benefiting from increased approvals of medications for RVO treatment. Notably, in September 2021, the FDA approved Byooviz (ranibizumab-nuna), the first biosimilar drug developed by Samsung Bioepis, for treating macular degeneration and other eye diseases, including RVO. This landmark approval is expected to drive significant growth in the industry.

Regional Market Insights:

North America held a substantial share of the global RVO market in 2022, owing to various factors such as advanced healthcare facilities, a high prevalence of eye disorders, cutting-edge technology, and an increasing aging population. The region’s robust infrastructure and high healthcare expenditure have been pivotal in supporting market growth.

Looking ahead, the Asia Pacific region is projected to experience the fastest growth, with a CAGR of 6.5% from 2023 to 2033. The rising prevalence of eye conditions, particularly in countries like China, Singapore, Indonesia, and other Southeast Asian nations, coupled with increasing healthcare spending, is expected to fuel market expansion in this region.

As the global population ages and the prevalence of retinal vein occlusion rises, the market for RVO treatments is set for substantial growth. Continued advancements in medical treatments and increased drug approvals will play a critical role in addressing this condition and improving the quality of life for affected individuals.

Key Takeaways from the Market Study:

Global retinal vein occlusion treatment market to reach a valuation of US$ 4.7 billion in 2033
East Asia retinal vein occlusion market is expected to expand at a CAGR of 6.5%.
From 2018 to 2022, sales increased significantly at a CAGR of 5%.
The random-effects gathered likelihood of RVO in Europeans over the age of 55 was 0.7%, according to a 2018 Pubmed report.
The total number of affected people in the EU is expected to nearly double, from 900,000 in 2018 to 1.1 million in 2050.

“Players in the retinal vein occlusion treatment domain are increasing their capacity to produce corticosteroid drugs, which can help combat the inflammatory factors that cause edema. Healthcare professionals, on the other hand, are becoming increasingly skilled in focal laser therapy,” says FMI’s analyst.

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!

Market Competition:

Key players in the retinal vein occlusion treatment market are AbbVie, Roche, Regeneron Pharmaceuticals, Taiwan Liposome Company, Aerie Pharmaceuticals, Graybug Vision, Kodiak Sciences Inc., Chugai Pharmaceuticals, and Novartis AG among others.

Novartis affirmed highly supportive for the initial interpretable Phase III findings of a clinical study investigating the effectiveness and protection of Beovu in December 2020. Beovu by Novartis placed Regeneron’s anti-VEGF Eylea, one of the renowned treatments for diabetic macular edema, in direct competition.
Roche is presently performing Phase III trials to examine the effectiveness and security of Faricimab in sick people with macular edema secondary to BRVO and CRVO, with the drug anticipated to be approved by 2023 based on the findings.

Key Segments Profiled in the Retinal Vein Occlusion Treatment Industry Survey:

By Drug Class:

Ranibizumab
Dexamethasone
Aflibercept
Bevacizumab

By Type:

Central Retinal Vein Occlusion
Branch Retinal Vein Occlusion

By Diagnosis:

Optical Coherence Tomography
Fundoscopic Examination
Fluorescein Angiography

By End User:

Hospitals
Research and Academics
Specialty Clinics

By Region:

North America
Europe
East Asia
South Asia
Oceania
Latin America
Middle East and Africa (MEA)

𝖤𝗑𝗉𝗅𝗈𝗋𝖾 𝖥𝖬𝖨’𝗌 𝖱𝖾𝗅𝖺𝗍𝖾𝖽 𝖮𝗇𝗀𝗈𝗂𝗇𝗀 𝖢𝗈𝗏𝖾𝗋𝖺𝗀𝖾 𝗈𝗇 𝖧𝖾𝖺𝗅𝗍𝗁𝖼𝖺𝗋𝖾 𝖬𝖺𝗋𝗄𝖾𝗍 𝖨𝗇𝗌𝗂𝗀𝗁𝗍𝗌 𝖣𝗈𝗆𝖺𝗂𝗇:

Submucosal Injections Industry

Wet Wipes Canister Industry

Enzyme Substrates Industry

About Future Market Insights (FMI)

Contact Us:

Global Hyaluronic Acid Personal Care Products Market Poised for Significant Growth USD 7.36 Billion by 2033

In 2033, the global market for hyaluronic acid personal care products is expected to reach USD 7.36 billion, up from USD 3.26 billion in 2023. This market is expected to register an 8.5% CAGR over the next few years, due to growing concerns about the appearance of aging populations.

It is easy to purchase these products online and through other retail channels, such as beauty salons, pharmacies, supermarkets, and specialty stores, without requiring a prescription. Hyaluronic acid improves the appearance of skincare products by reducing flaking and restoring suppleness to damaged or dry skin.

The use of hyaluronic acid, for instance, can reduce wrinkles, plump up the skin, and improve skin texture overall. Furthermore, the product offers moisture-retaining film properties, anti-wrinkle, anti-irritation properties, nutrition delivery, and free radical scavenging properties. Due to these properties, cosmetic-grade hyaluronic acid is also becoming increasingly popular in skincare, makeup, cleansing, and hair care.

Key Takeaways from Market Study:

The hyaluronic acid personal care products market is expected to record a CAGR of 8.5% over the forecast period.
According to estimates, the market in North America is likely to remain strong throughout the length of the forecast period.
In terms of product, the serum segment accounts for a significant share of the market, since they are more effective at penetrating the skin.
China holds a 40% share of the Asia Pacific market and is projected to expand at a CAGR of over 8.5%.

Enhanced Market Demand! Discover Thorough Trends and Insights in Our Complete Report!

Competitive Landscape:

Several prominent companies dominate this market, including Shiseido Co., Ltd., CeraVe, L’oréal Paris, La Roche Posay, Johnson & Johnson Consumer Inc. (Neutragena), SkinCeuticals, The Ordinary (Deceim Beauty Group, Inc.), Heraux (Carthronix), Innisfree (Amorepacific US, Inc.), Saro De Rúe, Beautiful Korea and others.

Several domestic and international manufacturers are present in the market, and they are continually investing in research and development, making the market highly fragmented. It is common for companies to innovate their products and collaborate with celebrities and social media influencers to gain more customers.

Manufacturers of these products can gain a larger share of the market, expand their product portfolios, and expand their geographical reach by engaging in these activities. By partnering with other companies, key players can also gain access to new markets and advanced technologies. They can also acquire companies, merge, and diversify their portfolios as well.

Recent Developments:

A freeze-dried hyaluronic acid system that offers clinically proven benefits for the skin was introduced by Saro De Re in January 2021.
In March 2021, Royal DSM, a global science-based company focused on nutrition, health, and sustainability, launched three forms of hyaluronic acid. HYA-ACT Medium Molecular Weight (MW 1.0-1.3 MDa) enhances skin hydration and strengthens the skin’s protective barrier. HYA-ACT XS Molecular Weight (MW 37-56 kDa) pumps out fine lines and wrinkles and locks in moisture for an even greater hydration boost and calms reddened skin, while HYA-ACT Small Molecular Weight (MW 200-400 kDa) locks in moisture for an even greater hydration boost and calms reddened skin.
In February 2020, Seikagaku Corporation, Japan-based pharmaceutical research and development company announced that it had acquired Dalton Chemical Laboratories Inc, a Canadian drug manufacturer. As a result of this acquisition, Seikagaku is able to strengthen its market position, as well as expand its research and development operations.

Key Segments:

By Product:

Skin Creams
Skin Lotions
Toner
Serum
Moisturize

By Price:

High/Premium
Medium
Low

By Application:

Dermal Fillers
Ophthalmic

By Distribution Channel:

Supermarket/Hypermarket
Specialty Stores
Company Owned Websites
Online Retailing

By Region:

North America
Latin America
Europe
The Middle East and Africa
East Asia

Photoacoustic Microscopy Industry

Rapid Hepatitis Testing Industry

Prefilled Hemostasis Agents Industry

About Future Market Insights (FMI)

Contact Us:

Global Super-Resolution Microscopes Market Set to Reach USD 9.5 Billion by 2033, Driven by Life Sciences and Nanotechnology Advancements | FMI

The super-resolution microscopes market is poised for significant growth, with revenues expected to reach USD 3.3 billion in 2023 and grow at a compound annual growth rate (CAGR) of 10.2% from 2023 to 2033. By the end of the forecast period, the market is projected to hit USD 9.5 billion, according to a new report from Future Market Insights.

Key factors driving this market expansion include increasing applications in the life science industry, ongoing technical advancements, and a rising focus on nanotechnology. Super-resolution microscopy, a powerful tool for high-precision imaging, has become increasingly essential for the identification of platelet granule abnormalities, which are linked to bleeding disorders caused by deficiencies in platelet granules.

Traditionally, diagnosing platelet-related bleeding problems required electron microscopy, which is often difficult to access and comes with notable drawbacks. However, with innovations in Structured-Illumination Microscopy (SIM), super-resolution imaging is now a faster, more efficient method for distinguishing between patients with platelet bleeding disorders and healthy individuals. This technological leap is contributing to a surge in market demand for super-resolution microscopes.

North America continues to dominate the market, accounting for over 30% of the global share in 2022. The region’s substantial investment in healthcare infrastructure, coupled with significant research and development expenditure, is expected to sustain its leadership. Moreover, North America’s focus on advancing drug development and the availability of reimbursement for medical treatments further bolsters the growth of the super-resolution microscopes market in the region.

As advancements in life sciences and nanotechnology continue to shape the future, super-resolution microscopes are set to play a pivotal role in revolutionizing diagnostic methods and contributing to groundbreaking research across various scientific fields.

Key Takeaways from the Super-resolution Microscopes Market Report:

Global Market Growth:
- The global super-resolution microscopes market revenue is projected to reach USD 3.3 billion in 2023.
- Anticipated to grow at a CAGR of 10.2% from 2023 to 2033, the market is expected to hit USD 9.5 billion by 2033.
Regional Insights:
- USA:
  - Estimated to reach USD 2.7 billion by 2033, with a CAGR of 10.9%.
  - Anticipates an absolute dollar growth of USD 1.7 billion from 2023 to 2033.
- United Kingdom:
  - Expected to reach a market valuation of USD 427 million by 2033.
  - Predicted to grow at a CAGR of 10.8%, contributing an absolute dollar opportunity of USD 272.8 million.
- China:
  - Market valuation forecasted at USD 1.4 billion by 2033, growing at an impressive CAGR of 12.4%.
  - Anticipates an absolute dollar growth of USD 991.6 million over the forecast period.
- Japan:
  - Projected to grow at a CAGR of 7.8%, reaching USD 7.8 million by 2033.
  - Expected to contribute an absolute dollar opportunity of USD 187.6 million during the forecast period.
- Key Drivers:
  - Increasing demand for super-resolution microscopes in academic life sciences, biotechnology, pharmaceuticals, and nanotechnology, especially in growth-centric markets like China.

This report underscores the burgeoning demand for advanced imaging technologies and the pivotal role of innovation in driving the global super-resolution microscopes market.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!

Competitive Landscape:

The key players operating in the global Super-resolution Microscopes Market are ZEISS, Applied Precision, Nikon Corporation, Olympus Corporation, and Leica Microsystems.

In January 2021, JEOL Ltd. unveiled the CRYO ARMT 300 II, which is an advanced cryo-electron microscope operating with cold field emission technology. The objective of this innovative cryo-EM was to make it quick and easy to use while getting high-contrast and elevated images.
In November 2020, Nikon Instruments Inc. announced the launch of the ECLIPSE Ei educational microscope which is designed for ease of use and enhanced learning.
In January 2020, Integrated Dynamic Electron Solutions, Inc., a start-up specializing in transmission electron microscopy technology was acquired by JEOL Ltd.

Market Segments Covered in Super-resolution Microscopes Market Analysis:

By Technology:

Stimulated Emission Depletion (STED) Microscopy
Structured-Illumination Microscopy (SIM)
Stochastic Optical Reconstruction Microscopy (STORM)
Fluorescence Photoactivation Localization Microscopy (FPALM)
Photoactivated Localization Microscopy (PALM)

By Application:

Nanotechnology
Life Science
Material Science
Semiconductor
Other Applications

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Blood Banking Equipment Industry

Mortuary Equipment Industry

Intracardiac Imaging Industry

About Future Market Insights (FMI)

Contact Us:

Stair Lifts and Climbing Devices Market Poised to Reach USD 6.9 Billion by 2033, Driven by Aging Population and Technological Advancements | FMI

The global stair lifts and climbing devices market is on a remarkable growth trajectory, with revenues estimated at USD 2.2 billion in 2023 and expected to surge to USD 6.9 billion by the end of 2033, according to a recent report by Future Market Insights. Key factors fueling this growth include an aging global population and the rapid evolution of mobility-enhancing technologies.

Market Drivers: Aging Population and Increased Prevalence of Arthritis

With over 350 million people worldwide affected by arthritis and osteoarthritis anticipated to become the fourth-largest cause of global disability, the demand for mobility solutions like stair lifts continues to rise. By 2050, the United Nations estimates that more than 20% of the global population will be over the age of 60, highlighting a pressing need for accessible mobility aids.

Technological Innovations Propel Market Expansion

The market is seeing significant technological advancements, including the development of outdoor, curved, and wheelchair-integrated stair lifts. Manufacturers are leveraging cutting-edge features to enhance user experience, catering to the increasing demand for personalized and efficient mobility solutions. Furthermore, financing options and free conveyance initiatives are making these devices more accessible to a broader demographic, boosting market adoption.

Regional Insights: North America Leads the Market

In 2022, North America emerged as a key revenue generator for the stair lifts and climbing devices market. Factors such as a growing disabled population and technological advancements have contributed to this dominance. According to the U.S. Census Bureau, the elderly population in America is projected to reach 1 billion by 2030, creating a significant demand for mobility-enhancing products.

Challenges: High Costs May Hinder Adoption

While the market outlook is promising, the cost of purchasing and installing stair lifts remains a potential barrier to widespread adoption. Manufacturers are addressing this challenge through cost-effective solutions and value-added services to sustain market momentum.

The stair lifts and climbing devices market is well-positioned for growth, supported by a combination of demographic trends, medical advancements, and innovative product development. As manufacturers continue to incorporate technologically advanced components into their offerings, the market is expected to witness sustained expansion over the next decade.

Increased Market Attention: Delve into Detailed Trends and Analysis with Our Report!

Key Takeaways from the Stair Lifts and Climbing Devices Market Report:

Global Market Overview
- 2023 Revenue: Estimated at USD 2.2 Billion.
- 2033 Forecast: Projected to reach USD 6.9 Billion, with a robust CAGR of 12% from 2023 to 2033.
United States Market
- 2033 Valuation: Expected to reach USD 2.7 Billion, growing at a CAGR of 13%.
- Key Drivers:
  - Increasing adoption of e-commerce for purchasing stair lifts, including refurbished products.
  - Integration of digital trends like virtual reality (VR) and 3D imaging to enhance product quality and installation efficiency.
- Growth Opportunity: An absolute dollar growth of USD 1.9 Billion is projected between 2023 and 2033.
United Kingdom Market
- 2033 Valuation: Forecast to reach USD 301 Million, with a CAGR of 8%.
- Growth Opportunity: Expected to achieve an absolute dollar growth of USD 202 Million.
Japan Market
- 2033 Valuation: Predicted at USD 263.5 Million, growing at a CAGR of 2%.
- Growth Opportunity: Anticipated absolute dollar growth of USD 165.2 Million.
South Korea Market
- 2033 Valuation: Expected to reach USD 135.1 Million, with a CAGR of 4%.
- Growth Opportunity: Estimated at USD 89.2 Million in absolute dollar terms.

Market Trends:

Technological Integration:
- Use of virtual reality and 3D imaging for product development, visualization, and installation optimization.
- Enhanced customer engagement through immersive visualization of product features, including rail colors and design.
E-commerce Expansion:
- The rise in online shopping for stair lifts, including refurbished options, is driving market accessibility and growth, particularly in the United States.

This report highlights the rapid growth trajectory of the stair lifts and climbing devices market, propelled by technological advancements and increasing consumer demand through digital channels.

Competitive Landscape:

The key players in the global Stair Lifts and Climbing Devices market are Brooks Stairlifts, Stannah, Handicare Group, Garaventa Lift, and Acorn Stairlifts.

In October 2021, The Garaventa Lift Group announced the launch of its first European Showroom in Switzerland. Switzerland is a vital market for the Group, thus this is a significant milestone in the company’s history.
In November 2020, Stannah created an e-commerce website where clients can buy a stair lift online. The company made its first sale in 82 minutes, signaling the successful launch of a significant new sales channel.

Key Companies Profiled:

Platinum Stairlifts
Bruno Independent Living Aids
ThyssenKrupp Elevator Technology
American Elevator
Precision Stairlifts

Market Segments Covered in Stair Lifts and Climbing Devices Market Analysis:

By Lift Type:

Stair Lifts
Stair Climbing Wheelchairs
Other Device Types

By End-Use:

Hospitals
Homecare
Other End-uses

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Disposable Medical Gowns Industry

Laryngeal Mask Industry

Cancer Gene Therapy Industry

About Future Market Insights (FMI)

Contact Us:

Source :

ALOHA4D

Global Infertility Drugs Market to Reach USD 6,814.68 Million by 2033 Amid Rising Prevalence of Infertility Worldwide | FMI

The global infertility drugs market, valued at USD 3,699.8 million in 2023, is projected to achieve significant growth, reaching USD 6,814.68 million by 2033. According to recent market analysis, this represents a compound annual growth rate (CAGR) of 6.3% during the forecast period. The increasing prevalence of infertility among both men and women is fueling the demand for effective infertility treatments.

Factors Driving Market Growth:

Infertility, affecting individuals of both genders, stems from various causes:

Female Infertility: Aging, polycystic ovarian syndrome (PCOS), obesity, and a history of miscarriages.
Male Infertility: Erectile dysfunction, low sperm count, and abnormal sperm production.

To address these challenges, researchers and market leaders are introducing innovative treatments. A notable breakthrough includes research by BGU scientists, who developed a new treatment stimulating telomerase expression to protect cells and improve fertility outcomes.

Pioneering Innovations in Infertility Treatments:

Several pharmaceutical companies are leading the charge with first-in-class infertility solutions:

Oxolife’s OXO-001: Designed to enhance embryo implantation by improving binding with the uterine lining.
Ferring Pharmaceuticals’ Trisequens: A novel fertility treatment tailored to improve conditions for embryo implantation, addressing critical needs in assisted reproduction.

In addition, in-vitro fertilization (IVF) is becoming a mainstream treatment option, significantly contributing to the market’s expansion. IVF’s success in overcoming fertility challenges is further supported by advancements in hormonal treatments and specialized medications.

Lifestyle Trends and Regulatory Challenges:

The rising prevalence of sedentary lifestyles, hormonal imbalances, and PCOS has increased the demand for effective infertility drugs. However, growth is tempered by stringent regulatory frameworks for product approvals and the high costs of patented treatments, presenting challenges for manufacturers and healthcare providers.

Future Outlook:

With continued innovation, the availability of diverse infertility treatments, and increasing awareness of fertility issues, the global infertility drugs market is poised for robust growth. Industry stakeholders remain focused on addressing regulatory hurdles while advancing affordable, effective solutions to meet growing demand.

Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends!

Key Takeaways from Market Study:

The infertility drugs market is expected to record a CAGR of 6.3% over the forecast period.
According to estimates, the infertility drugs market in North America may remain strong throughout the length of the forecast period.
The gonadotropins segment dominated the infertility drugs market with a revenue share of 40.1% in 2023 and is expected to grow rapidly.
The women’s segment dominated the market for infertility drugs in 2023 with a revenue share of 71.3%.

Competitive Landscape:

Several prominent companies dominate this market, including Ferring Pharmaceuticals Inc., Merck KGaA, Bayer AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Theramex, Novartis AG., Abbott Laboratories, Bayer AG, Novartis AG, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sanofi S.A., Ferring Holdings SA, Organon & Co., Mankind Pharma Ltd., and others.

Recent Developments:

Genea Biomedx (Australia) partnered with Hamilton Thorne in 2020 to sell its fertility products in the United States and Canada.
The Pergoveris Pen is the first pen injector for gonadotropins, which are hormones that play a crucial role in reproduction and fertility. It was introduced to India in August 2021 by Merck, to treat infertility.
The Fertility Partners, the leading provider of fertility services in Canada, has partnered with Maven Clinic to form a referral network for fertility clinics. Maven’s network helps its members find high-quality fertility care in over 70 countries. The company also launched MavenRx, its new medication service, in February 2020, to help fertility members get their medications more seamlessly.

Infertility Drugs Market Segmentation by Category:

By Drug Class:

Gonadotrophins
Aromatase Inhibitors
Selective Estrogen Receptor Modulators (SERMs)
Biguanides
Other Drug Classes

By End User:

Male
Female

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels

By Region Outlook:

North America
Latin America
Europe
The Middle East and Africa
East Asia

Women Digital Health Solutions Industry

Oxygen Conservation Devices Industry

Biodegradable Gloves Industry

About Future Market Insights (FMI)

Contact Us: